Search Tag: Critical Care
2024 27 Nov
U.S. FDA approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the critical care setting. AOP Orphan Pharmaceuticals GmbH (AOP Health) , based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for Rapiblyk TM (landiolol) in the hospital critical...Read more